Get notified when QURE files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Passive Foreign Investment Company (new) — The company was a PFIC for the 2024 taxable year, triggering adverse U.S. federal income tax consequences for U.S. holders.
NASDAQ: QURE uniQure N.V. 424B5

uniQure prices offering of ordinary shares and pre-funded warrants at $44.39/share; size redacted

Filed June 22, 2026 · ~2 min read

Offering filing cluster

Same offering
  1. 424B5 Jun 22, 2026 This filing EDGAR →
  2. 424B5 Jun 24, 2026 uniQure prices $225M IPO at $45.50/share, plans Q3 2026 BLA submission for AMT-130 EDGAR →
  3. 8-K Jun 24, 2026 uniQure prices $243M equity offering, issuing 5.7M shares at $45.50 with full greenshoe EDGAR →

Key Changes

  • high

    uniQure is offering ordinary shares and pre-funded warrants at $44.39 per share (matching June 22, 2026 Nasdaq close), with a 15% underwriter over-allotment option; specific share quantities and total proceeds are redacted from this 424B5.

    The Offering verify on EDGAR →
  • high

    The filing omits all use-of-proceeds detail, stating only that net proceeds will be used "as set forth in the applicable prospectus supplement." Investors do not know how much capital is being raised or how it will be allocated.

    Use of Proceeds verify on EDGAR →
  • high

    uniQure plans to submit a BLA for AMT-130 (Huntington's disease) in Q3 2026 following FDA feedback that three-year Phase I/II data would support accelerated approval; FDA requires alignment on a confirmatory study design (without sham procedure) and expects the study underway before BLA approval.

    Risk Factors verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FDS 10-Q) is open in full — no account needed.

Partner

Trade QURE commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Source-verified from EDGAR · Narrative written by AI · Jul 7, 2026 · How we verify